nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—ADA—brown adipose tissue—adrenal gland cancer	0.242	0.493	CbGeAlD
Vidarabine—ADK—Nucleotide metabolism—RRM1—adrenal gland cancer	0.0354	0.0888	CbGpPWpGaD
Vidarabine—ADK—adrenal cortex—adrenal gland cancer	0.0332	0.0676	CbGeAlD
Vidarabine—Clofarabine—RRM1—adrenal gland cancer	0.0324	0.292	CrCbGaD
Vidarabine—Fludarabine—RRM1—adrenal gland cancer	0.0313	0.283	CrCbGaD
Vidarabine—ADORA2A—gonad—adrenal gland cancer	0.0306	0.0624	CbGeAlD
Vidarabine—ADA—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.0304	0.0765	CbGpPWpGaD
Vidarabine—ADA—adrenal gland—adrenal gland cancer	0.0293	0.0597	CbGeAlD
Vidarabine—ADK—gonad—adrenal gland cancer	0.0275	0.056	CbGeAlD
Vidarabine—ADK—cardiac atrium—adrenal gland cancer	0.0275	0.0559	CbGeAlD
Vidarabine—ADK—pituitary gland—adrenal gland cancer	0.0268	0.0546	CbGeAlD
Vidarabine—Cladribine—NR5A1—adrenal gland cancer	0.0268	0.242	CrCbGaD
Vidarabine—ADORA2A—adrenal gland—adrenal gland cancer	0.0267	0.0543	CbGeAlD
Vidarabine—ADA—Nucleotide metabolism—RRM1—adrenal gland cancer	0.024	0.0604	CbGpPWpGaD
Vidarabine—DPP4—Peptide hormone metabolism—REN—adrenal gland cancer	0.024	0.0602	CbGpPWpGaD
Vidarabine—ADK—adrenal gland—adrenal gland cancer	0.024	0.0488	CbGeAlD
Vidarabine—DPP4—adrenal gland—adrenal gland cancer	0.0232	0.0473	CbGeAlD
Vidarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—TOP2A—adrenal gland cancer	0.0223	0.0559	CbGpPWpGaD
Vidarabine—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CTNNB1—adrenal gland cancer	0.0189	0.0475	CbGpPWpGaD
Vidarabine—Cladribine—RRM1—adrenal gland cancer	0.0186	0.168	CrCbGaD
Vidarabine—ADORA2A—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.0175	0.0439	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Other—GNRHR—adrenal gland cancer	0.0173	0.0435	CbGpPWpGaD
Vidarabine—DPP4—Incretin synthesis, secretion, and inactivation—CTNNB1—adrenal gland cancer	0.0168	0.0422	CbGpPWpGaD
Vidarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—adrenal gland cancer	0.00913	0.0229	CbGpPWpGaD
Vidarabine—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN2A—adrenal gland cancer	0.00817	0.0205	CbGpPWpGaD
Vidarabine—DPP4—Peptide hormone metabolism—POMC—adrenal gland cancer	0.00799	0.0201	CbGpPWpGaD
Vidarabine—ADORA2A—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.00722	0.0181	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00696	0.0175	CbGpPWpGaD
Vidarabine—ADA—p73 transcription factor network—RB1—adrenal gland cancer	0.00685	0.0172	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00645	0.0162	CbGpPWpGaD
Vidarabine—ADA—C-MYB transcription factor network—CDKN2A—adrenal gland cancer	0.00573	0.0144	CbGpPWpGaD
Vidarabine—DPP4—Peptide hormone metabolism—CTNNB1—adrenal gland cancer	0.0057	0.0143	CbGpPWpGaD
Vidarabine—ADA—C-MYB transcription factor network—PTGS2—adrenal gland cancer	0.00536	0.0135	CbGpPWpGaD
Vidarabine—ADK—Metabolism—SDHB—adrenal gland cancer	0.00498	0.0125	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00491	0.0123	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—REN—adrenal gland cancer	0.00453	0.0114	CbGpPWpGaD
Vidarabine—ADORA2A—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.0042	0.0105	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.004	0.01	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00386	0.0097	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PRKACA—adrenal gland cancer	0.00345	0.00867	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00344	0.00865	CbGpPWpGaD
Vidarabine—ADA—Metabolism—SDHB—adrenal gland cancer	0.00339	0.00851	CbGpPWpGaD
Vidarabine—ADK—Metabolism—RRM1—adrenal gland cancer	0.00321	0.00807	CbGpPWpGaD
Vidarabine—ADK—Metabolism—SDHD—adrenal gland cancer	0.00321	0.00807	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00294	0.00739	CbGpPWpGaD
Vidarabine—ADORA2A—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00283	0.0071	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00277	0.00697	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PRKACA—adrenal gland cancer	0.00266	0.00667	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00262	0.00658	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00252	0.00633	CbGpPWpGaD
Vidarabine—ADK—Metabolism—MED12—adrenal gland cancer	0.00239	0.00601	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—IGF2—adrenal gland cancer	0.00226	0.00567	CbGpPWpGaD
Vidarabine—ADA—Metabolism—RRM1—adrenal gland cancer	0.00218	0.00548	CbGpPWpGaD
Vidarabine—ADA—Metabolism—SDHD—adrenal gland cancer	0.00218	0.00548	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	0.00204	0.00513	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	0.00186	0.00467	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PRKACA—adrenal gland cancer	0.00175	0.00439	CbGpPWpGaD
Vidarabine—Adenosine triphosphate—ABCB1—adrenal gland cancer	0.00168	0.0151	CrCbGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00166	0.00417	CbGpPWpGaD
Vidarabine—ADA—Metabolism—MED12—adrenal gland cancer	0.00163	0.00409	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—TP53—adrenal gland cancer	0.00159	0.00399	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—BAD—adrenal gland cancer	0.00157	0.00395	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00152	0.00383	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00151	0.00379	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—POMC—adrenal gland cancer	0.00151	0.00379	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00149	0.00374	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00148	0.00372	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—BRAF—adrenal gland cancer	0.00143	0.00359	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GNAS—adrenal gland cancer	0.00142	0.00356	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ABCB1—adrenal gland cancer	0.00139	0.00349	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00138	0.00347	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00135	0.00339	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00135	0.00338	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0013	0.00327	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PRKACA—adrenal gland cancer	0.00119	0.00298	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CTNNB1—adrenal gland cancer	0.00108	0.0027	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	0.00107	0.00268	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—POMC—adrenal gland cancer	0.00103	0.00258	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000965	0.00242	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GNAS—adrenal gland cancer	0.000962	0.00242	CbGpPWpGaD
Vidarabine—ADK—Metabolism—POMC—adrenal gland cancer	0.000953	0.00239	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ABCB1—adrenal gland cancer	0.000944	0.00237	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—TP53—adrenal gland cancer	0.000912	0.00229	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000902	0.00226	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000891	0.00224	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000862	0.00216	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—EGFR—adrenal gland cancer	0.000819	0.00206	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000819	0.00206	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000815	0.00205	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000795	0.002	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000782	0.00197	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGS2—adrenal gland cancer	0.00076	0.00191	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000747	0.00188	CbGpPWpGaD
Vidarabine—ADA—Metabolism—POMC—adrenal gland cancer	0.000648	0.00163	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.00058	0.00146	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.00057	0.00143	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000527	0.00132	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS2—adrenal gland cancer	0.000517	0.0013	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000484	0.00122	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000466	0.00117	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000462	0.00116	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000451	0.00113	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000388	0.000975	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BAD—adrenal gland cancer	0.000338	0.000848	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—POMC—adrenal gland cancer	0.000311	0.000782	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000307	0.000772	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000298	0.000748	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000222	0.000558	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EGFR—adrenal gland cancer	0.000176	0.000442	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TP53—adrenal gland cancer	0.000148	0.000371	CbGpPWpGaD
